𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Postresection hepatic failure: Successful treatment with liver transplantation

✍ Scribed by Yuichiro Otsuka; John P. Duffy; Sammy Saab; Douglas G. Farmer; Rafik M. Ghobrial; Jonathan R. Hiatt; Ronald W. Busuttil


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
252 KB
Volume
13
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


Postoperative liver failure (PLF) is a rare but often fatal complication of major hepatic resection. Use of orthotopic liver transplantation (OLT) for PLF remains undefined. We conducted a retrospective review of 435 patients who underwent hepatic resection between 1990 and 2004; 9 of them (2.0%) developed PLF. Indications for resection included primary hepatic malignancies (8), colonic metastases (2), and echinococcic cyst (1); all resections were multisegmental, 6 were extended, and 2 were lobectomies. A total of 7 patients underwent OLT at a mean of 25 days after resection. Patients developing PLF had significantly lower preoperative platelet counts and significant elevations of total bilirubin, direct bilirubin, prothrombin time, and international normalized ratio (INR) by postoperative day 2. Pathological cirrhosis and extended right lobectomy were associated with significantly increased risk of PLF. Following OLT, there were no in-hospital deaths, but 1 patient required retransplantation for primary nonfunction. Mean survival with and without OLT was 42.2 and 1.4 months, respectively (P Ο­ 0.03). Following OLT, 1-and 5-yr patient survivals were 88% and 40%, respectively; 1-and 5-yr graft survivals were 75% and 34%, respectively. In conclusion, patients with low platelets, biopsy-proven cirrhosis, or those undergoing extended resection are at increased risk for PLF. OLT for PLF has significant morbidity but allows salvage of an otherwise fatal condition. Liver


πŸ“œ SIMILAR VOLUMES


Antituberculous therapy–induced fulminan
✍ Ramazan Idilman; Sadik Ersoz; Sahin Coban; Ozlem Kumbasar; Hakan Bozkaya πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

Standard antituberculous therapy including isoniazid, rifampin, ethambutol, and pyrazinamide is widely used for the treatment of active tuberculosis. Its most important side effect is hepatotoxicity, ranging from asymptomatic transaminitis to fulminant hepatic failure. A 19-year-old woman was admitt

Terbinafine-induced hepatic failure requ
✍ Zeeshan Perveze; Mark W. Johnson; Raymond A. Rubin; Marty Sellers; Carlos Zayas; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 198 KB

Drug-induced liver disease accounts for about 50% of acute or subacute liver failure in the United States. United Network of Organ Sharing (UNOS) data suggest 8%-20% of liver transplantation in this country per year is for fulminant liver failure due to drugs. Even though the most common medication

Liver transplantation for fulminant hepa
✍ Wall, William J. ;Adams, Paul C. πŸ“‚ Article πŸ“… 1995 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 462 KB

s an indication for transplantation, fulminant A hepatic failure (FHF) accounts for approximately 7% of the liver transplantations currently performed in the United States and This percentage is very small in comparison with the number of transplants performed for chronic liver disease, but FHF domi